The global insulin market is on a steady growth trajectory, projected to increase from USD 20.3 billion in 2024 to over USD 31.5 billion by the end of 2035, expanding at a CAGR of 4.1% from 2025 to 2035. This expansion is primarily driven by the alarming rise in global diabetes prevalence, coupled with ongoing innovations in insulin delivery systems and government healthcare initiatives....